4th Quarter - Report

ALCON LABORATORIES, INC. for ALCON LABORATORIES INC

Firm
Client
Income
—
Expenses
$210,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues concerning Medicare reimbursement for ambulatory surgical center and hospital outpatient prospective payment systems.

Foreign entity interest: Novartis AG, a foreign Swiss entity, is the majority owner of Alcon, Inc. as of August 25, 2010 when they purchased the remainder of Nestle, SAs interests. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.

LobbyistCovered position, as disclosed
BRETTE MCCLELLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

510K regulatory approval process for medical devices.

Foreign entity interest: Novartis AG, a foreign Swiss entity, is the majority owner of Alcon, Inc. as of August 25, 2010 when they purchased the remainder of Nestle, SAs interests. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.

LobbyistCovered position, as disclosed
BRETTE MCCLELLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.